UKPDS Cardiac Risk Calculator : r/MecSimCalc
Coronary heart disease risk assessment in diabetes mellitus: comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications - Song - 2004 - Diabetic Medicine - Wiley Online Library
Translating and piloting a cardiovascular risk assessment and management online tool using mobile technology - ScienceDirect
Evaluation of risk equations for prediction of short-term coronary heart disease events in patients with long-standing type 2 diabetes: the Translating Research into Action for Diabetes (TRIAD) study | BMC Endocrine Disorders
Patient reactions to a web-based cardiovascular risk calculator in type 2 diabetes: a qualitative study in primary care | British Journal of General Practice
GPs' familiarity with and use of cardiovascular clinical prediction rules: a UK survey study | BJGP Open
Example of calculating cardiovascular risk with the use of a UKPDS... | Download Scientific Diagram
UKPDS 60 | Stroke
EPIRxISK
Keeping the diabetic heart healthy
RLC_RJS_RRH Risk Engine_abstract_ADA 2012 WEB
Risk Engine — Radcliffe Department of Medicine
UKPDS Cardiac Risk Calculator | MecSimCalc
Cardiovascular Risk Assessment in Metabolic Syndrome and Diabetes | SpringerLink
UKPDS Risk : Cloud Practice
Cardiovascular risk algorithms in primary care: Results from the DETECT study | Scientific Reports
UKPDS-CV Risk by Headcan
Calculadora UKPDS-RE: após preencher as informações solicitadas no... | Download Scientific Diagram
LNICST 83 - Risk Assessment Models for Diabetes Complications: A Survey of Available Online Tools
UKPDS risk engine. T2DM-specific risk calculator. Based on 53 000... | Download Scientific Diagram
UKPDS-CV Risk by Headcan
Cardiovascular risk
UKPDS Risk Engine 2.0 Download (Free) - RiskEng.EXE
Hypertension Dr. Elizabeth Swiggum, Cardiologist Dr. Anthony Nielsen, Medical Lead CVRR. - ppt download
Patient reactions to a web-based cardiovascular risk calculator in type 2 diabetes: a qualitative study in primary care
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) - The Lancet
